Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Acta Neurologica Scandinavica|March 1, 1992
Clinical status of motoneuron disease does not correlate with serum neurotoxicity on cultured neuronsJ Martí-Fàbregas, R Soler, J Esquerda, et al.Annals of Neurology|August 1, 1995
Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosidesI Illa, N Ortiz, E Gallard, et al.Muscle & Nerve|July 1, 1997
Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological studyJ Berciano, J Figols, A García, et al.Autoimmunity|November 15, 2000
Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studiesG M O'Hanlon, J Veitch, E Gallardo, et al.Neurology|December 12, 2001
Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patientsE Gallardo, R Rojas-García, N de Luna, et al.Neurology|March 26, 2003
Myasthenia gravis: a higher than expected incidence in the elderlyJ M Aragonès, I Bolíbar, X Bonfill, et al.Neuroscience Letters|September 13, 2005
Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase geneC Paradas, I Fernandez-Cadenas, E Gallardo, et al.The New England Journal of Medicine|April 19, 1990
Mitochondrial myopathy caused by long-term zidovudine therapyM C Dalakas, I Illa, G H Pezeshkpour, et al.Gut|April 1, 1988
Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathyR Cervera, J Bruix, A Bayes, et al.Journal of Neuroimmunology|August 30, 2001
IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter releaseN Ortiz, R Rosa, E Gallardo, et al.Pageof 8